Evidence map›Paper›PMID 38767202›Full record

ReviewEmerging microbes & infections2024

Climate change, its impact on emerging infectious diseases and new technologies to combat the challenge.

Hongyan Liao, Christopher J Lyon, Binwu Ying, Tony Hu

Abstract readReview
In one paragraph

Review in Emerging microbes & infections, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Animal organoids as models for integrated One Health research.One health (Amsterdam, Netherlands) · 2026
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hongyan LiaoDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Christopher J LyonCenter for Cellular and Molecular Diagnostics and Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, United States.
Binwu YingDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Tony HuCenter for Cellular and Molecular Diagnostics and Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, United States.

Funding

Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHPR01HD103511 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI LYON, CHRISTOPHER J · 2021 to 2025
$3.7M
A nanopore biosensor for leveling Mtb antigens in bloodR01AI144168 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI Christopher J Lyon · 2022 to 2026
$3.0M
Rapid Detection of TB from Blood using Cell-Free DNA and CRISPRR01AI174964 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Richard S Garfein, Timothy Charles Rodwell · 2023 to 2026
$2.9M
Multiplexed detection of cell-free M. Tuberculosis DNA and its drug-resistant variants in bloodR01AI175618 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI Zhen Huang, Jeffrey Tornheim · 2023 to 2026
$2.9M
Diagnostic Innovations for Pediatric Tuberculosis in BoliviaR01AI173021 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI ROBERT H GILMAN, Bo Ning · 2023 to 2026
$2.8M
CRISPR detection of circulating cell-free Mycobacterium avium complex (MAC) DNA for rapid diagnosis and monitoring of MAC pulmonary diseaseR01AI177986 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bo Ning, Kevin Loring Winthrop · 2024 to 2026
$2.3M
CRISPR-TB for pediatric TB diagnosis and treatment responseR01AI179714 · NIAID · UNIVERSITY OF WASHINGTON · PI Sylvia LaCourse · 2024 to 2026
$2.2M
NIAID NIH HHS R01 AI144168NIAID NIH HHS R01 AI173021NIAID NIH HHS R01 AI174964NIAID NIH HHS R01 AI175618NIAID NIH HHS R01 AI177986NIAID NIH HHS R01 AI179714NICHD NIH HHS R01 HD103511
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Climate ChangeCommunicable Diseases, EmergingAnimalsDisease OutbreaksHumansclimate changeearly diagnosisEmerging infectious diseaseoutbreaktransmission

Identifiers

PMID38767202
PMCPMC11138229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.